Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04147650 · ClinicalTrials.gov registry record · Phase 2
Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye Syndrome
A Phase 2 study, sponsored by Aurinia Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 508
- Enrollment target
NCT04147650 is a Phase 2 study that has completed, run by Aurinia Pharmaceuticals. The registered enrollment target is 508 participants.
The verdict
NCT04147650, a Phase 2 study, has completed, sponsored by Aurinia Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 508 participants
- Enrollment target
Study Summary
A Multi-Center, Phase 2/3, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial to Assess the Safety and Efficacy of Voclosporin Ophthalmic Solution (0.05%, 0.10%, 0.20%) Compared to Vehicle in Subjects with Dry Eye Syndrome.
Interventions
- DRUG Vehicle Ophthalmic Solution
- DRUG 0.05% Voclosporin Ophthalmic Solution (VOS)
- DRUG 0.10% VOS
- DRUG 0.20% VOS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 508 participants |
| Start Date | 2019-10-14 |
| Est. Completion | 2020-10-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04147650
The ClinicalTrials.gov registry entry for NCT04147650 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 508 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aurinia Pharmaceuticals, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Vehicle Ophthalmic Solution is the first listed.
NCT04147650 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04147650 about?
NCT04147650 is a clinical study titled "Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye Syndrome". A Multi-Center, Phase 2/3, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial to Assess the Safety and Efficacy of Voclosporin Ophthalmic Solution (0.05%, 0.10%, 0.20%) Compared to Vehicle in Subjects with Dry Eye Syndrome.
What is the current status of trial NCT04147650?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 508 participants. The study started on 2019-10-14. Estimated completion is 2020-10-08.
What interventions are being tested in trial NCT04147650?
The interventions under investigation include: Vehicle Ophthalmic Solution (DRUG), 0.05% Voclosporin Ophthalmic Solution (VOS) (DRUG), 0.10% VOS (DRUG), 0.20% VOS (DRUG).
Who is sponsoring clinical trial NCT04147650?
This trial is sponsored by Aurinia Pharmaceuticals, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.